Physician profile
Victoria Jd Marks
NPI 1558748343
$373.36
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $341 · 2023: $32.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $91.71 | 2021-2023 | Ozempic |
| Abbvie INC. | $43.75 | 2021 | |
| Astellas Pharma US INC | $39.96 | 2021 | |
| Amgen INC. | $37.13 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $33.08 | 2021 | |
| Merck Sharp & Dohme LLC | $29.04 | 2021 | |
| Vivus LLC | $22.41 | 2021 | |
| Abbott Laboratories | $21.40 | 2021 | |
| Optinose US, INC. | $19.75 | 2021 | |
| Amarin Pharma, INC. | $18.45 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.